Advertisement
Screener

METAVIA INC. (MTVA) Operating Cash Flow

2.8 / 5 stars · 68/120 Roast Me

METAVIA INC. Operating Cash Flow

METAVIA INC. (MTVA) reported Operating Cash Flow of -$8.02 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.

Financial Statements › Cash Flow › Operating Activities

us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-06

  • METAVIA INC. net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was -$3.76M.
  • METAVIA INC. net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was -$4.26M.
  • METAVIA INC. net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was -$4.86M.
  • METAVIA INC. net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was -$2.96M.
  • METAVIA INC. net cash provided by (used in) operating activities for fiscal 2025 was -$15.70M.
  • METAVIA INC. net cash provided by (used in) operating activities for fiscal 2024 was -$24.71M.
  • METAVIA INC. net cash provided by (used in) operating activities for fiscal 2023 was -$10.80M.
  • METAVIA INC. net cash provided by (used in) operating activities for fiscal 2022 was -$11.71M.
Period endNet Cash Provided by (Used in) Operating Activities 3 monthNet Cash Provided by (Used in) Operating Activities 3 month as first filedNet Cash Provided by (Used in) Operating Activities 6 monthNet Cash Provided by (Used in) Operating Activities 6 month as first filedNet Cash Provided by (Used in) Operating Activities 9 monthNet Cash Provided by (Used in) Operating Activities 9 month as first filedNet Cash Provided by (Used in) Operating Activities 12 monthNet Cash Provided by (Used in) Operating Activities 12 month as first filed
2026-06-30-$3.76M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06
-$8.02M
10-Q · filed 2026-08-06
-$12.88M
derived: sum of 3 quarters · filed 2026-08-06
-$15.84M
derived: sum of 4 quarters · filed 2026-08-06
2026-03-31-$4.26M
10-Q · filed 2026-05-14
-$9.12M
derived: sum of 2 quarters · filed 2026-05-14
-$12.07M
derived: sum of 3 quarters · filed 2026-05-14
-$15.14M
derived: sum of 4 quarters · filed 2026-08-06
2025-12-31-$4.86M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26
-$7.82M
derived: sum of 2 quarters · filed 2026-03-26
-$10.89M
derived: sum of 3 quarters · filed 2026-08-06
-$15.70M
10-K · filed 2026-03-26
2025-09-30-$2.96M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06
-$6.03M
derived: sum of 2 quarters · filed 2026-08-06
-$10.84M
10-Q · filed 2025-11-06
-$16.31M
derived: sum of 4 quarters · filed 2026-08-06
2025-06-30-$3.07M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06
-$7.89M
10-Q · filed 2026-08-06
-$13.36M
derived: sum of 3 quarters · filed 2026-08-06
-$18.90M
derived: sum of 4 quarters · filed 2026-08-06
2025-03-31-$4.82M
10-Q · filed 2026-05-14
-$10.28M
derived: sum of 2 quarters · filed 2026-05-14
-$15.83M
derived: sum of 3 quarters · filed 2026-05-14
-$23.08M
derived: sum of 4 quarters · filed 2026-05-14
2024-12-31-$5.47M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26
-$11.02M
derived: sum of 2 quarters · filed 2026-03-26
-$18.27M
derived: sum of 3 quarters · filed 2026-03-26
-$24.71M
10-K · filed 2026-03-26
2024-09-30-$5.55M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06
-$12.80M
derived: sum of 2 quarters · filed 2025-11-06
-$19.24M
10-Q · filed 2025-11-06
-$19.28M
10-Q · filed 2024-11-07
-$22.63M
derived: sum of 4 quarters · filed 2025-11-06
2024-06-30-$7.25M
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07
-$13.69M
10-Q · filed 2025-08-07
-$17.09M
derived: sum of 3 quarters · filed 2025-08-07
-$19.90M
derived: sum of 4 quarters · filed 2025-08-07
2024-03-31-$6.44M
10-Q · filed 2025-05-14
-$9.84M
derived: sum of 2 quarters · filed 2025-05-14
-$12.65M
derived: sum of 3 quarters · filed 2025-05-14
-$14.69M
derived: sum of 4 quarters · filed 2025-05-14
2023-12-31-$3.39M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-20
-$6.21M
derived: sum of 2 quarters · filed 2025-03-20
-$8.25M
derived: sum of 3 quarters · filed 2025-03-20
-$10.80M
10-K · filed 2025-03-20
2023-09-30-$2.81M
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07
-$4.86M
derived: sum of 2 quarters · filed 2024-11-07
-$7.41M
10-Q · filed 2024-11-07
-$9.21M
derived: sum of 4 quarters · filed 2024-11-07
2023-06-30-$2.04M
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14
-$4.59M
10-Q · filed 2024-08-14
-$6.40M
derived: sum of 3 quarters · filed 2024-08-14
-$8.76M
derived: sum of 4 quarters · filed 2024-08-14
2023-03-31-$2.55M
10-Q · filed 2024-05-09
-$4.35M
derived: sum of 2 quarters · filed 2024-05-09
-$6.71M
derived: sum of 3 quarters · filed 2024-05-09
-$9.43M
derived: sum of 4 quarters · filed 2024-05-09
2022-12-31-$1.81M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28
-$4.17M
derived: sum of 2 quarters · filed 2024-03-28
-$6.88M
derived: sum of 3 quarters · filed 2024-03-28
-$11.71M
10-K · filed 2024-03-28
2022-09-30-$2.36M
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13
-$5.08M
derived: sum of 2 quarters · filed 2023-11-13
-$9.90M
10-Q · filed 2023-11-13
-$12.80M
derived: sum of 4 quarters · filed 2023-11-13
2022-06-30-$2.72M
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09
-$7.55M
10-Q · filed 2023-08-09
-$10.45M
derived: sum of 3 quarters · filed 2023-08-09
-$12.95M
derived: sum of 4 quarters · filed 2023-08-09
2022-03-31-$4.83M
10-Q · filed 2023-05-12
-$7.73M
derived: sum of 2 quarters · filed 2023-05-12
-$10.23M
derived: sum of 3 quarters · filed 2023-05-12
-$13.82M
derived: sum of 4 quarters · filed 2023-05-12
2021-12-31-$2.90M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30
-$5.41M
derived: sum of 2 quarters · filed 2023-03-30
-$8.99M
derived: sum of 3 quarters · filed 2023-03-30
-$15.13M
10-K · filed 2023-03-30
2021-09-30-$2.51M
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14
-$6.09M
derived: sum of 2 quarters · filed 2022-11-14
-$12.23M
10-Q · filed 2022-11-14
-$14.58M
derived: sum of 4 quarters · filed 2022-11-14
2021-06-30-$3.59M
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12
-$9.73M
10-Q · filed 2022-08-12
-$12.08M
derived: sum of 3 quarters · filed 2022-08-12
-$14.03M
derived: sum of 4 quarters · filed 2022-08-12
2021-03-31-$6.14M
10-Q · filed 2022-05-13
-$8.49M
derived: sum of 2 quarters · filed 2022-05-13
-$10.44M
derived: sum of 3 quarters · filed 2022-05-13
-$12.77M
derived: sum of 4 quarters · filed 2022-05-13
2020-12-31-$2.35M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31
-$4.30M
derived: sum of 2 quarters · filed 2022-03-31
-$6.63M
derived: sum of 3 quarters · filed 2022-03-31
-$10.76M
10-K · filed 2022-03-31
2020-09-30-$1.95M
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15
-$4.28M
derived: sum of 2 quarters · filed 2021-11-15
-$8.42M
10-Q · filed 2021-11-15
-$9.69M
derived: sum of 4 quarters · filed 2021-11-15
2020-06-30-$2.32M
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-16
-$6.46M
10-Q · filed 2021-08-16
-$7.74M
derived: sum of 3 quarters · filed 2021-08-16
-$11.09M
derived: sum of 4 quarters · filed 2021-08-16
2020-03-31-$4.14M
10-Q · filed 2021-05-17
-$5.42M
derived: sum of 2 quarters · filed 2021-05-17
-$8.76M
derived: sum of 3 quarters · filed 2021-05-17
-$9.95M
derived: sum of 4 quarters · filed 2021-05-17
2019-12-31-$1.28M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-04-15
-$4.62M
derived: sum of 2 quarters · filed 2021-04-15
-$5.82M
derived: sum of 3 quarters · filed 2021-04-15
-$7.04M
10-K · filed 2021-04-15
2019-09-30-$3.35M
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-13
-$4.54M
derived: sum of 2 quarters · filed 2020-11-13
-$5.76M
10-Q · filed 2020-11-13
-$6.83M
10-Q · filed 2019-11-08
-$2.41M
derived: sum of 4 quarters · filed 2020-11-13
2019-06-30-$1.19M
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-11
-$2.42M
10-Q · filed 2020-08-11
-$5.04M
10-Q · filed 2019-08-09
$931.00K
derived: sum of 3 quarters · filed 2020-08-11
-$3.35M
derived: sum of 4 quarters · filed 2020-08-11
2019-03-31-$1.22M
10-Q · filed 2020-05-20
-$3.17M
10-Q · filed 2019-05-09
$2.12M
derived: sum of 2 quarters · filed 2020-05-20
-$2.16M
derived: sum of 3 quarters · filed 2020-05-20
-$8.44M
derived: sum of 4 quarters · filed 2020-05-20
2018-12-31$3.35M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-30
-$937.00K
derived: sum of 2 quarters · filed 2020-03-30
-$7.21M
derived: sum of 3 quarters · filed 2020-03-30
-$14.45M
10-K · filed 2020-03-30
-$21.91M
10-K · filed 2019-03-18
2018-09-30-$4.28M
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08
-$10.56M
derived: sum of 2 quarters · filed 2019-11-08
-$17.80M
10-Q · filed 2019-11-08
-$24.56M
derived: sum of 4 quarters · filed 2019-11-08
2018-06-30-$6.28M
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09
-$13.51M
10-Q · filed 2019-08-09
-$20.27M
derived: sum of 3 quarters · filed 2019-08-09
-$27.57M
derived: sum of 4 quarters · filed 2019-08-09
2018-03-31-$7.24M
10-Q · filed 2019-05-09
-$14.00M
derived: sum of 2 quarters · filed 2019-05-09
-$21.30M
derived: sum of 3 quarters · filed 2019-05-09
-$27.91M
derived: sum of 4 quarters · filed 2019-05-09
2017-12-31-$6.76M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-18
-$14.06M
derived: sum of 2 quarters · filed 2019-03-18
-$20.68M
derived: sum of 3 quarters · filed 2019-03-18
-$26.90M
10-K · filed 2019-03-18
2017-09-30-$7.30M
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08
-$13.92M
derived: sum of 2 quarters · filed 2018-11-08
-$20.14M
10-Q · filed 2018-11-08
-$23.76M
derived: sum of 4 quarters · filed 2019-03-18
2017-06-30-$6.62M
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-14
-$12.84M
10-Q · filed 2018-08-14
-$16.46M
derived: sum of 3 quarters · filed 2019-03-18
-$20.10M
derived: sum of 4 quarters · filed 2019-03-18
2017-03-31-$6.22M
10-Q · filed 2018-05-08
-$9.85M
derived: sum of 2 quarters · filed 2019-03-18
-$13.48M
derived: sum of 3 quarters · filed 2019-03-18
2016-12-31-$3.62M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-18
-$7.26M
derived: sum of 2 quarters · filed 2019-03-18
-$11.04M
10-K · filed 2019-03-18
2016-09-30-$3.63M
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-13
-$7.42M
10-Q · filed 2017-11-13
2016-06-30-$3.79M
10-Q · filed 2017-08-14
2015-12-31-$5.43M
10-K · filed 2018-03-20

Similar stocks

Stock NameCountryMarket CapPE Ratio
KALA BIO, Inc. (KALA)United States$0.011B-3.33
Moleculin Biotech, Inc. (MBRX)United States$0.011B
Theriva Biologics, Inc. (TOVX)United States$0.011B
Azitra, Inc. (AZTR)United States$0.010B-0.81
Dare Bioscience, Inc. (DARE)United States$0.011B
Medicus Pharma Ltd. (MDCX)$0.010B
KIORA PHARMACEUTICALS INC (KPRX)United States$0.012B
Scienture Holdings, Inc. (SCNX)United States$0.012B-0.38
Aprea Therapeutics, Inc. (APRE)United States$0.010B-0.78
Phio Pharmaceuticals Corp. (PHIO)United States$0.012B-0.92